Category: scientific-advisors

Dr. Robert Segal is Board Certified Internist/ Nephrologist with more than 20 years of broad experience in drug/device development, global clinical research, regulatory strategy/authority interaction, government funding and scientific affairs. He is thorough familiarity with aspects related to intellectual property and orphan drug/fast track applications. He has received Federal and Biodefense funding and contracts, including five NIH SBIR (Small Business Innovative Research) grants/contracts worth around $10 Million.
 
Dr. Segal holds an active MD license in Pennsylvania and previously got licensed in Maryland, California, the UK and South Africa.

Dr. Andrew Whelton is Professor of Medicine (Adjunct), also ex-Director of the Division of Nephrology at The Johns Hopkins University School of Medicine. He has over 50 years of pharmaceutical experiences and focuses on Clinical Drug Development and Safety. He is a Special Government Officer, Consultant to the Food and Drug Administration and Member, ad hoc, Arthritis Advisory Committee Food and Drug Administration, appointed by Federal Government since 1990s.

Dr. Whelton is also an expert in the field of renal disease and cardiovascular. He has authored over one hundred and eighty scientific articles, book chapters and reviews on the topics of renal disease, cardiovascular, hyperuricemia and gout. Besides, he was appointed as Chairman of Maryland Commission on Kidney Disease.

Dr. N. Lawrence Edwards is Professor of Medicine, Division of Rheumatology and Clinical Immunology, as well as Program Director and Vice Chairman of the Department of Medicine at the University of Florida in Gainesville. He is the Chairman and CEO of the Gout Education Society, a non-profit, patient education organization, for the past 14 years (www.gouteducation.org). Dr. Edwards is an active member of many professional organizations including the American College of Rheumatology, American College of Physicians, the Association of Program Directors in Internal Medicine and is Past-President of the National Society of Clinical Rheumatologists.

Dr. Edwards obtained his undergraduate training at the University of Notre Dame and his medical degree from the University of Miami School of Medicine. He has authored over one hundred and fifty scientific articles, book chapters and reviews on the topics of hyperuricemia, gout, and purine metabolism.

Dr. William White is Professor of Medicine and Chief of the Division of Hypertension and Clinical Pharmacology in the Calhoun Cardiology Center at the University of Connecticut School of Medicine where he has worked for 40 years. In addition, Dr. White is the founder and former Medical Director of the Clinical Trials Unit at the University of Connecticut Health Center in Farmington.

Dr. White graduated from Emory University with a Bachelor of Science Degree in Biology/Chemistry and obtained his medical degree from Medical College of Georgia.  He is the author of over 475 articles and book chapters, mainly in the field of cardiovascular medicine and therapeutics.